Literature DB >> 18982469

Optimal scan time of oxygen-15-labeled gas inhalation autoradiographic method for measurement of cerebral oxygen extraction fraction and cerebral oxygen metabolic rate.

Miho Shidahara1, Hiroshi Watabe, Kyeong Min Kim, Nobuyuki Kudomi, Hiroshi Ito, Hidehiro Iida.   

Abstract

OBJECTIVE: Regional cerebral blood flow (CBF), cerebral blood volume, oxygen extraction fraction (OEF), and cerebral metabolic rate of oxygen (CMRO2) can be estimated from C15O, H(2)15O, and 15O2 tracers and positron emission tomography (PET) using an autoradiographic (ARG) method. Our objective in this study was to optimize the scan time for 15O2 gas study for accurate estimation of OEF and CMRO2.
METHODS: We evaluated statistical noise in OEF by varying the scan time and error caused by the tissue heterogeneity in estimated OEF and CMRO2 using computer simulations. The characteristics of statistical noise were investigated by signal-to-noise (S/N) ratio from repeated tissue time activity curves with noise, which were generated using measured averaged arterial input function and assuming CBF=20, 50, and 80 (ml/100 g per minute). Error caused by tissue heterogeneity was also investigated by estimated OEF and CMRO2 from tissue time activity curve with mixture of gray and white matter varying fraction of mixture. In the simulations, three conditions were assumed (i) CBF in gray and white matter (CBFg and CBFw) was 80 and 20, OEF in gray and white matter (Eg and Ew) was 0.4 and 0.3, (ii) CBFg and CBFw decreased by 50%, and Eg and Ew increased by 50% when compared with conditions (i) and (iii). CBFg and CBFw decreased by 80%, and Eg and Ew increased by 50% when compared with condition (i).
RESULTS: The longer scan time produced the better S/N ratio of estimated OEF value from three CBF values (20, 50, and 80). Errors of estimated OEF for three conditions owing to tissue heterogeneity decreased, as scan time took longer. Meanwhile in the case of CMRO2, 3 min of scan time was desirable.
CONCLUSIONS: The optimal scan time of 15O2 inhalation study with the ARG method was concluded to be 3 min from taking into account for maintaining the S/N ratio and the quantification of accurate OEF and CMRO2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982469     DOI: 10.1007/s12149-008-0157-9

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  Noninvasive estimation of the arterial input function in positron emission tomography imaging of cerebral blood flow.

Authors:  Yi Su; Ana M Arbelaez; Tammie L S Benzinger; Abraham Z Snyder; Andrei G Vlassenko; Mark A Mintun; Marcus E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

2.  Effects of a novel tungsten-impregnated rubber neck shield on the quality of cerebral images acquired using 15O-labeled gas.

Authors:  Kei Wagatsuma; Keiichi Oda; Kenta Miwa; Motoki Inaji; Muneyuki Sakata; Jun Toyohara; Kiichi Ishiwata; Masayuki Sasaki; Kenji Ishii
Journal:  Radiol Phys Technol       Date:  2017-08-19

3.  Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

Authors:  S Hara; Y Tanaka; S Hayashi; M Inaji; T Maehara; M Hori; S Aoki; K Ishii; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

4.  Intravoxel incoherent motion perfusion in patients with Moyamoya disease: comparison with 15O-gas positron emission tomography.

Authors:  Shoko Hara; Masaaki Hori; Ryo Ueda; Akifumi Hagiwara; Shihori Hayashi; Motoki Inaji; Yoji Tanaka; Taketoshi Maehara; Kenji Ishii; Shigeki Aoki; Tadashi Nariai
Journal:  Acta Radiol Open       Date:  2019-05-23

Review 5.  Quantification of brain oxygen extraction and metabolism with [15O]-gas PET: A technical review in the era of PET/MRI.

Authors:  Audrey P Fan; Hongyu An; Farshad Moradi; Jarrett Rosenberg; Yosuke Ishii; Tadashi Nariai; Hidehiko Okazawa; Greg Zaharchuk
Journal:  Neuroimage       Date:  2020-07-04       Impact factor: 6.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.